An appropriate cuff according to the individual's arm circumference is recommended with all blood pressure (BP) monitors. An electronic device for home monitoring has been developed (Visomat Comfort 20/40) that estimates the individual's arm circumference by measuring the cuff filing volume and makes an adjustment of measured BP taking into account the estimated arm circumference. Thus the manufacturer recommends the use of a single cuff for arm circumference 23-43 cm. The device accuracy was assessed using the European Society of Hypertension International Protocol. Simultaneous BP measurements were obtained in 33 adults by two observers (connected mercury sphygmomanometers) four times, sequentially with three measurements taken using the tested device. Absolute device-observer BP differences were classified into p5, p10 and p15 mm Hg zones. For each participant the number of measurements with a difference p5 mm Hg was calculated. The device produced 60/89/97 measurements within 5/10/15 mm Hg respectively for systolic BP, and 72/97/98 for diastolic. Twenty-three subjects had at least two of their systolic BP differences p5 mm Hg and three had no differences p5 mm Hg (for diastolic 27 and 1, respectively). Mean deviceobserver BP difference (systolic/diastolic) was 3.7 ± 5.6/À1.5±4.7 mm Hg (4.7±4.9/À1.7±4.3 in arm circumference 23-29 cm [39 readings] and 3.1 ± 5.9/À1.4 ± 5.0 in arm 30-34 cm [60 readings], P ¼ NS). In conclusion, the device fulfils the International Protocol requirements and can be recommended for clinical use. Interestingly, the device was accurate using a single cuff in a wide range of arm circumference (23-34 cm). This study provides no information about the device accuracy in larger arms.
Introduction
Home monitoring of blood pressure (BP) is regarded as a useful adjunct to conventional office measurements.
1-3 Semiautomatic electronic devices, which eliminate the observer bias and are easy to use, are preferred for self-home BP monitoring. [1] [2] [3] However, few of the electronic devices available on the market for home BP monitoring have been subjected to independent validation using established protocols and proved to be accurate. 4 The cuff with its inflatable bladder is an important component of the BP monitor, which might significantly affect the measurement accuracy. 2, 5 In 1986 the British Hypertension Society recommended the use of a single cuff with bladder size 35 Â 12 cm for BP measurement in all the adults. 6 However, it has been shown that the use of a small cuff in large arms leads to significant BP overestimation, whereas a large cuff in small arms leads to BP underestimation. 2, 5 Therefore, current guidelines by the American Heart Association, 1 the European Society of Hypertension 2 and the British Hypertension Society 7 recommend that several cuffs of difference size should be available and that the inflatable bladder should cover 80-100% of the arm circumference of each individual. However, this approach is not particularly practical because it requires wide availability of a variety of cuffs and measurement of each individual's arm circumference. 2, 5 Several approaches have been proposed to deal with the issue of miscuffing, yet none has been completely satisfactory. 2 Correction formulae have been proposed to adjust the measurement error due to inappropriate cuff size but have been found impractical and were not widely used. 2 A cuff with three inflatable cuffs of difference sizes has been developed (Tricuff, Pressure Group AB and Co KB, AJ Medical HB, Sweden), but because of practical problems and cost it did not become popular. 8 Another cuff with a clamping mechanism has also been developed for use in all arm sizes (Adjustacuf, AC Cossor and Sons Ltd, London, UK), but again has not been extensively studied or used. 2, 5 The accuracy of the oscillometric BP measurement that is the standard method of all electronic BP monitors is also affected by the cuff size and therefore two or three cuffs of different size are usually available for each of these devices. A novel oscillometric device has been recently designed for home BP measurement (Visomat Comfort 20/40), which uses a single cuff in subjects with a wide range of arm circumference. This study presents the results of a validation study of this device according to the European Society of Hypertension International Protocol. 9 
Methods

Tested device
The Visomat Comfort 20/40 (UEBE Medical GmbH Wertheim, Germany) is an oscillometric device for upper-arm home BP measurement. It measures BP during inflation, which is performed by an automatic electric pumping system. It has a novel technology that estimates the individual's arm circumference by measuring the cuff filing volume and a microprocessor makes an adjustment of measured BP by taking into account the estimated arm circumference. This correction feature aims to provide accurate BP measurements by using a single cuff in subjects with a wide range of arm size. Thus, a cuff with inflatable bladder 22.5 Â 12.5 cm is recommended by the manufacturer for use in subjects with arm circumference 23-43 cm. Three devices were obtained from the manufacturer together with a written declaration that they were standard production models. One of these devices was randomly selected for the validation procedure.
Blood pressure measurements
One supervisor and two trained observers collaborated through the entire validation procedure. Before the study the observers were tested for their agreement in BP measurement with simultaneous measurements taken using Y-connected mercury devices on five subjects (10 measurements per subject; total of 50; at least 45 BP differences should be p5 mm Hg and at least 48 p10 mm Hg). 9 Two calibrated mercury sphygmomanometers (Riester, diplomat-presameter, Rud. Riester GmbH Co. KG, Jungingen, Germany) and a teaching Littman stethoscope were used for simultaneous (Y tube) observertaken reference BP measurements. The supervisor measured BP with the tested device and also checked the agreement of BP measurements taken by the observers, who were blinded from each other's readings and those obtained by the device. Observer readings with a difference 44 mm Hg were repeated until closer agreement was reached. A single cuff was used with the tested device for all participants and three cuffs with the mercury device (bladder size to cover 80-100% of arm circumference of each individual). All measurements were taken on the left arm, which was supported at heart level.
Procedure
According to the International Protocol, a total of 15 treated or untreated subjects who fulfil the protocol requirements are included in phase 1. If analysis of these data is successful, additional subjects are recruited until a total of 33 subjects fulfil the protocol requirements for phase 2. Recruitment started focusing on subjects with high diastolic and low systolic BP, and later on high systolic and low diastolic BP and the middle BP groups were filled in the end. The study was conducted in an isolated and quite room. After 10-15 min sitting rest, BP was measured by the observers (entry BP) to classify subjects into the low, medium and high range. A single measurement taken by the supervisor using the tested device followed. The two observers then took four readings using the mercury devices (BP1, BP3, BP5 and BP7) sequentially with three measurements taken by the supervisor using the tested device (BP2, BP4 and BP6). These last seven measurements (BP1-BP7) were used in the validation analysis. The protocol was accepted by the hospital scientific committee and written informed consent was obtained from all participants.
Analysis
According to the International Protocol each pair of observer measurements was averaged and was then subtracted from the device measurement. The absolute BP2-BP1, BP2-BP3, BP4-BP3, BP4-BP5, BP6-BP5 and BP6-BP7 differences were calculated and paired according to the device reading. For each pair, the one with the smaller difference was selected. These differences were classified into three zones (within 5, 10 and 15 mm Hg), for systolic and diastolic BP, for 15 subjects in phase 1 and for all the 33 in phase 2. For each individual the number of readings with a difference within 5 mm Hg was also calculated. Statistical analysis was performed using the MINITAB INC Statistical Software (release 13.31, Stage College, PA, USA).
Results
Study participants
Forty-four subjects were recruited from an Outpatient's BP Clinic and from patients and staff of a University Department of Medicine. Three were excluded due to arrhythmia, two due to procedure interruption (persistent cough, mobile telephone), one due to high entry BP and five because entry BP did not fit within the ranges required by the International Protocol. In 16 of the 132 readings there was a 44 mm Hg difference between the observers' measurements and were repeated to reach closer agreement.
The first 15 participants who fulfilled the protocol criteria regarding sex and entry BP were included in the analysis of phase 1 (7 men, mean age 54.4±12.7 years (range 33-73), arm circumference 29.8 ± 2.8 cm (range 23-34), entry systolic BP 144.1 ± 23.7 mm Hg (range 103-178) and diastolic 87.2±17.4 mm Hg (range 59-111)). Analysis of phase 2 was based on the first 33 participants who fulfilled the criteria regarding sex and entry BP (17 men, mean age 51.2±12.4 years (range 33-73), arm circumference 29.7±3.1 cm (range 23-34), entry systolic BP 143.2 ± 23.8 mm Hg (range 102-178) and diastolic 87.8 ± 17.1 mm Hg (range 59-112)). In 13 subjects the small cuff was used for observers' measurements, in 20 the medium-size cuff and the large cuff in none.
Validation criteria
The use of the tested device was straightforward with no operational problems during the study. There was one failure of the device to record BP throughout the study, which was successful on repeated measurement.
In both phases 1 and 2.1 of the International Protocol the tested device passed all the criteria for systolic and diastolic BP (Table 1) . Twenty-three subjects had at least two of their triplicate systolic BP differences p5 mm Hg and three had no differences p5 mm Hg (for diastolic 27 and 1 respectively), and therefore the phase 2.2 criteria of the International Protocol were fulfilled (Table 1) . The BP differences between the tested device and the observer readings are presented in Figure 1 . The mean BP difference between the device and the reference method was 3.7±5.6 mm Hg for systolic and À1.5 ± 4.7 mm Hg for diastolic BP.
In 13 subjects (39 BP readings) with arm circumference 23-29 cm (mean 26.5±1.9 cm) in whom the small cuff was used for observer measurements, the device-observer BP difference was 4.7 ± 4.9 mm Hg for systolic and À1.7±4.3 mm Hg for diastolic BP. In the rest 20 subjects (60 BP readings) with arm circumference 30-34 cm (mean 31.7 ± 1.4 cm) who used the medium-size cuff for observer measurements, the BP difference was 3.1±5.9 mm Hg for systolic and À1.4 ± 5.0 mm Hg for diastolic BP (P ¼ NS for difference from subjects with arm circumference 23-29 cm for both systolic and diastolic BP). There was a weak inverse association between arm circumference and the device-observer BP difference for systolic (r ¼ À0.18, P ¼ 0.08) but not diastolic BP (r ¼ 0.02, P ¼ 0.90).
Discussion
This study provides a formal validation of the Visomat Comfort 20/40 oscillometric device designed for home BP monitoring using a single cuff in subjects with a wide range of arm size. The device passed all the validation requirements of the International Protocol 9 and therefore can be recommended for clinical use in the adult population. It should be noted that all the validation criteria consistently showed better accuracy of the device in measuring diastolic rather than systolic BP suggesting that there is potential for improvement in the measurement algorithm. Abbreviations: DBP, diastolic blood pressure; Mean diff., mean difference; Recomm., Recommendation; SBP, systolic blood pressure.
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The challenging feature of this device is the use of a single cuff for arm circumference 23-43 cm. Although several cuffs of different sizes are available with most BP monitors, the arm size often is not taken into account for cuff selection and miscuffing is particularly common also with home BP monitoring. 5, 10 Furthermore, home monitors are often used by more than one person who might need different cuffs. Therefore, any improvement in technology that addresses the miscuffing issue is welcome and might improve the accuracy of BP measurement in clinical practice. Another interesting feature of the tested device is that it measures BP during inflation, reducing thereby the time needed for BP measurement. This is a potential advantage that deserves further evaluation because in obese subjects cuff inflation can be painful and might affect BP measurement.
Interestingly, the device accuracy (mean deviceobserver BP difference and standard deviation) was similar in subjects with arm circumference 23-29 cm in whom the device's cuff size was appropriate and also in those with arm circumference 30-34 cm in whom the cuff is regarded as small. Thus, the BP adjustment technology implemented in the device appears to be successful. Furthermore, the device satisfied the validation criterion of the Association for the Advancement of Medical Instrumentation protocol, 11 given that the mean device-observer BP difference was o5 mm Hg and its standard deviation o8 mm Hg in both the subgroups with small and large arm.
It should be mentioned that the International Protocol does not take into account the different cuffs used in the validation procedure but gives an overall estimation of the device accuracy irrespectively of the cuffs used. 9 Although the International Protocol requires only 33 subjects, because three pairs of device-observer readings are obtained per participant the subgroup analysis according to cuff size was based on 39 pairs of readings with the small cuff and 60 with the medium-size cuff (subgroup of interest due to inappropriate cuff size). However, because the participants' arm circumference ranged from 23 to 34 cm, this study does not provide information on the device accuracy in larger arms up to 43 cm, as recommended by the manufacturer. A separate validation study specifically including subjects with large arms is needed to provide clear insight into this interesting technological feature of the device. What is known about this topic K The inflatable cuff is an important component of all blood pressure monitors. Three cuffs of different size should be available to fit the arm circumference of all individuals.
What the study adds K A novel electronic device (Visomat Comfort 20/40) estimates the arm circumference of each individual by measuring the cuff filing volume and makes an adjustment of measured blood pressure. K The device fulfils the requirements of the European Society of Hypertension International Protocol and appears to be accurate using a single cuff in a wide range of arm circumference (23-34 cm).
